FDA Issues Recalls and Warnings for Multiple Medications, Including a Blood Pressure Drug and GLP-1 Pens

The FDA has announced several medication recalls and warnings, including chlorthalidone 25 mg tablets, which have been recalled for a second time in three months due to dissolution issues. Additionally, some exenatide injection (GLP-1 pens) are being recalled due to a defective delivery system that may result in no medication being present in prefilled pens. Other recalled drugs include fluphenazine hydrochloride, nystatin cream, olanzapine tablets, and ranolazine extended-release tablets. These actions are categorized based on health risk, with Class I being the most serious.